![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Benagiano G, Fraser I. The Depo-provera debate. Contraception 1981; 24: 493–528
- Briggs M., Briggs M. The Development of a New Triphasic Oral Contraceptive, R. B. Greenblatt. MTP Press, Lancaster 1980; 79
- Howard G., Elder M. G., Fotherby K. The use of norethisterone oenanthate an injectable contraceptive in patients at risk of venous thrombosis. Hormones and Vascular Disease, R. M. Greenhalgh. Pitman Medical, London 1981; 294
- Howard G., Blair M., Fotherby K., Trayner I., Hamawi A., Elder M. G. Some metabolic effects of long term use of the injectable contraceptive norethisterone oenanthate. Lancet 1982; i: 423–425
- Jain A. K. Cigarette smoking, use of oral contraceptives, and myocardial infarction. American Journal of Obstetrics and Gynecology. 1976; 126: 301–307
- Kremer J., Bruijn H. W. A., Hindriks F. R. Serum high density lipoprotein cholesterol levels in women using a contraceptive injection of depot medroxy-progesterone acetate. Contraception 1980; 22: 359–367
- Miller N. E., Thelle D. S., Førde O. H., Mjøs O. D. High density lipoprotein and coronary heart disease. A prospective case control study. Lancet 1977; 1: 965–968
- Tuttle S., Turkington V. E. Effects of medroxyprogesterone acetate on carbohydrate metabolism. Obstetrics and Gynecology 1974; 43: 685–692
- Upton G. V. The Development of a New Triphasic Oral Contraceptive, R. B. Greenblatt. MTP Press, Lancaster 1980; 31
- Vessey M. P., Doll R. Investigation of relation between use of oral contraceptives and thromboembolic disease: a further report. British Medical Journal 1968; ii: 651–657
- World Health Organization. Multinational comparable clinical trial of long-acting injectable contraceptives: norethisterone oenanthate given in two dosage regimens and depot-medroxy progesterone acetate. A preliminary report. Contraception 1982; 25: 1